Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1451

1.

Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?

Chua B, Ung O, Taylor R, Boyages J.

ANZ J Surg. 2002 Nov;72(11):786-92.

PMID:
12437688
2.

Frequency and predictors of axillary lymph node metastases in invasive breast cancer.

Chua B, Ung O, Taylor R, Boyages J.

ANZ J Surg. 2001 Dec;71(12):723-8.

PMID:
11906387
3.

[Management of the axilla in breast cancer: evidences and unresolved issues].

Fodor J, Polgár C, Péley G, Németh G.

Orv Hetil. 2001 Sep 9;142(36):1941-50. Review. Hungarian.

PMID:
11680099
4.

Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?

Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.

Chir Ital. 2007 Sep-Oct;59(5):693-9.

PMID:
18019642
5.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
6.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
7.

Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.

Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, Vicini FA.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):658-70.

PMID:
12788171
8.

The value of level III clearance in patients with axillary and sentinel node positive breast cancer.

Dillon MF, Advani V, Masterson C, O'Loughlin C, Quinn CM, O'Higgins N, Evoy D, McDermott EW.

Ann Surg. 2009 May;249(5):834-9. doi: 10.1097/SLA.0b013e3181a40821.

PMID:
19387317
9.

The importance of extracapsular extension of axillary lymph node metastases in breast cancer.

Ilknur GB, Hilmi A, Tülay C, Oguz C, Selma S, Serdar S, Uğur Y, Pinar B, Omer H, Münir K; Dokuz Eylül University Medical Faculty Breast Tumors Study Group.

Tumori. 2004 Jan-Feb;90(1):107-11.

PMID:
15143982
10.

Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.

Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB.

Br J Surg. 2003 Nov;90(11):1354-60.

PMID:
14598414
11.

The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?

Wong JS, O'Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):133-7.

PMID:
10924982
12.

Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer.

Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Bruzzi P, Badellino F.

Eur J Surg Oncol. 1998 Apr;24(2):104-9.

PMID:
9591024
13.

Is information from axillary dissection relevant to patients with clinically node-negative breast cancer?

Chua B, Ung O, Taylor R, Boyages J.

Breast J. 2003 Nov-Dec;9(6):478-84.

PMID:
14616942
14.
15.

Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.

Breast J. 2004 Mar-Apr;10(2):101-5.

PMID:
15009035
16.

Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.

Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1074-9.

PMID:
15234041
17.

Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.

Tan LG, Tan YY, Heng D, Chan MY.

Singapore Med J. 2005 Dec;46(12):693-7.

18.

[Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].

Ouyang T, Li JF, Wang TF, Lin BY.

Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):298-300. Chinese.

PMID:
15842936
19.
20.

Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Giuliano AE, Kirgan DM, Guenther JM, Morton DL.

Ann Surg. 1994 Sep;220(3):391-8; discussion 398-401.

Supplemental Content

Support Center